Continual Improvement of the Pharmaceutical Quality System
Throughout the conference, participants will have been shown how the key elements that make up a successful pharmaceutical quality system can be implemented in a practical way including continual improvement of products and processes. Once the pharmaceutical quality system is established it will need to be maintained and developed.
The final session focuses on continual improvement of the pharmaceutical quality system itself. The session will show how the system contributes to its own improvement as well as the internal and external factors that must be taken into account to keep the system fit for purpose.
|Wednesday 16 November 2011|
|13:00||13:30||The Importance of Continually Improving Your PQS
Jacques Morénas, French Agency for the Safety of Health Products (AFSSAPS)
|13:30||14:00||Case Study: How do You Know if Your PQS is a Healthy One?
Zena Kaufman, Abbott Laboratories
|14:00||14:30||Complacency is not an Option
Vicki Soteres, Eli Lilly
Jacques Morénas, AFSSAPS; Zena Kaufman, Abbott Laboratories; Vicki Soteres, Eli Lilly; Mike James, GlaxoSmithKline; Rob Hughes, Astra-Zeneca
|15:00||15:15||Close of Session
David Cockburn, EMA
|Monday 14 November 2011||Tuesday 15 November 2011||Wednesday 16 November 2011|
Plenary Session 1 & 2:
Plenary Sessions 3 & 4:
Plenary Session 5:
Plenary Session 6:
Plenary Session 7:
Plenary Session 9:
Plenary Session 10:
Plenary Session 11:
|Monday 14 November 2011|
|Exhibition Networking Reception|